Late HIV diagnosis in Europe: a call for increased testing and awareness among general practitioners

The European Journal of General Practice
Meaghan M KallValerie Delpech

Abstract

Major advancements in the treatment of HIV infection mean near normal life expectancy of persons diagnosed at an early stage of infection. Nevertheless, a significant proportion of HIV infected persons remain undiagnosed and are diagnosed at a late stage of infection, putting them at higher risk for preventable HIV-related morbidity and mortality and risking onward transmission to others. In Europe, half of people diagnosed with HIV in 2010 were diagnosed late with a CD4<350 cells/ul, at a point after which treatment should have begun. The causes of late diagnosis are manifold, and comprise barriers to testing at the patient, healthcare provider, and institutional level. Strategies to address barriers to HIV testing are essential to ensure prompt diagnosis. Routine universal HIV testing in general practice consisting of informed consent and a pre-test discussion is feasible and acceptable and should be considered in high prevalence areas to normalize HIV testing, reduce stigma, and reduce the number of infected individuals who are diagnosed late.

References

Aug 1, 1996·Annals of Emergency Medicine·P L AlpertR S Klein
Jul 11, 2003·Lancet·A MocroftUNKNOWN EuroSIDA study group
Apr 6, 2004·Journal of General Internal Medicine·Rebecca V LiddicoatJeffrey H Samet
May 17, 2005·BMJ : British Medical Journal·Ann K SullivanMargaret A Johnson
Feb 28, 2006·The Lancet Infectious Diseases·Adrian R LevyJulio S Montaner
May 26, 2007·International Journal of STD & AIDS·Cyrille DelpierreUNKNOWN VESPA Study Group
Jun 30, 2007·BMJ : British Medical Journal·Cyrille DelpierreFrance Lert
Sep 28, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Enrico GirardiAntonella D'Arminio Monforte
Jul 2, 2008·HIV Medicine·F F Hamers, A N Phillips
Jul 2, 2008·HIV Medicine·I FakoyaI Shiripinda
Jul 3, 2008·JAMA : the Journal of the American Medical Association·Krishnan BhaskaranUNKNOWN CASCADE Collaboration
Nov 14, 2008·AIDS·Andrew N PhillipsJens D Lundgren
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Colleen F KelleySteven G Deeks
Jul 9, 2009·AIDS·Nicole CrepazUNKNOWN HIV/AIDS Prevention Research Synthesis (PRS) Team
Sep 23, 2009·AIDS·Alison D GrantUNKNOWN United Kingdom Collaborative HIV Cohort Study Group
Feb 4, 2010·European Journal of Public Health·Jessika DeblondeMarleen Temmerman
May 26, 2010·International Journal of STD & AIDS·C R EmersonJ J Post
Jul 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kenneth A LichtensteinUNKNOWN HIV Outpatient Study (HOPS) Investigators
Oct 27, 2010·PloS One·Yazdan YazdanpanahA David Paltiel
Jul 7, 2011·AIDS Research and Therapy·Patricia Garcia de OlallaUNKNOWN HIV Surveillance Group
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team

❮ Previous
Next ❯

Citations

May 10, 2016·The International Journal on Drug Policy·Mostafa ShokoohiAli Mirzazadeh
Feb 20, 2014·Journal of Immigrant and Minority Health·Adebola A AdedimejiYvette Calderon
Jun 23, 2018·International Journal of Environmental Research and Public Health·Donna Angelina RadeGraham Brown
May 6, 2019·Health Promotion International·Hanne ApersUNKNOWN HERMETIC Study Group
Dec 27, 2019·International Quarterly of Community Health Education·Behzad DehghaniJamal Sarvari
Jun 20, 2020·Journal of Addictive Diseases·Azadeh BayaniBahram Armoon
Jun 27, 2020·Journal of the International Association of Providers of AIDS Care·Ann Dalton Bagchi, Tracy Davis
Oct 24, 2018·BMC Public Health·Jessika DeblondeUNKNOWN HERMETIC Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.